Arthur T. Sands - Feb 14, 2023 Form 4 Insider Report for Nurix Therapeutics, Inc. (NRIX)

Role
President, CEO, Director
Signature
/s/ Daniel Burbach, as Attorney-in-Fact for Arthur T. Sands
Stock symbol
NRIX
Transactions as of
Feb 14, 2023
Transactions value $
$0
Form type
4
Date filed
2/15/2023, 03:12 PM
Previous filing
Aug 10, 2022
Next filing
Feb 15, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NRIX Employee Stock Option (right to buy) Award $0 +448K $0.00 448K Feb 14, 2023 Common Stock 448K $10.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 1/36 of the total shares monthly beginning March 14, 2023 until the option is fully vested on February 14, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Remarks:

Exhibit 24 - Power of Attorney